Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles by Staff

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD  |  April 1, 2013

 Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis

Anthony S. Russell, MA, MB, BCHIR  |  April 1, 2013

 Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events

Letter: Should We Monitor Asymptomatic Hyperuricemia?

William Treuhaft, MD  |  March 1, 2013

Why have physicians stopped routine screening for hyperuricemia and is there any value to this screening?

Letter: There’s No Reason Now to Screen for Uric Acid

Robert H. Shmerling, MD  |  March 1, 2013

Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned

In Memoriam: Rheumatology Loses Dedicated Pediatric Rheumatologist

Staff  |  March 1, 2013

Suzanne L. Bowyer, MD served as chief of the division of rheumatology at the Riley Hospital for Children in Indianapolis and director of the fellowship program from 2003 until 2012

Why Universal Access to Healthcare Isn’t a Constitutional Right, It’s Just Plain Fair

Richard Brasington, MD  |  March 1, 2013

One rheumatologist forms his opinion on the topic while fly fishing on rivers in Missouri

Blue Ribbon Panel on Academic Rheumatology Publishes Final Report

Staff  |  March 1, 2013

Report offers recommendations to address critical issues with training, practice, and research

The ACR’s Simple Tasks Campaign Expands its Reach, Launches a Blog, and Earns its Fourth Award

Staff  |  March 1, 2013

Simple Tasks exhibited at the annual meetings of two physician groups, and recently hand-delivered ACR materials to lawmakers on Capitol Hill

What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics

Staff  |  March 1, 2013

The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics

ACR Adopts Strategic Plan to Advance Rheumatology

Staff  |  March 1, 2013

Recommendations in the areas of healthcare economics, rheumatology practice, and research are included in the ACR’s strategic plan for 2013 – 2016

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 150
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences